Federica Sallusto

Federica Sallusto

Auto-generated profile, based on publicly available information

Federica Sallusto

Institute for Research in Biomedicine, Università della Svizzera italiana 1 , Bellinzona

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 March 2022 in Science
Verified
Journal Article
Closed access
MMMiriam Merad
Miriam Merad
CBCatherine A. Blish
Catherine A. Blish
FSFederica Sallusto
Federica Sallusto
AIAkiko Iwasaki
Akiko Iwasaki
Considerable research effort has been made worldwide to decipher the immune response triggered upon severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections, identify the drivers of severe and fatal COVID-19, and understand what leads to the prolongation of symptoms after disease resolution. We review the results of almost 2 years of COVID-19 immunology research and discuss definitive findings and remaining questions regarding our understanding of COVID-19 pathophysiology. We discuss emerging understanding of differences in immune responses seen in those with and without Long Covid syndrome, also known as post-acute sequelae of SARS-CoV-2. We hope that the knowledge gained from this COVID-19 research will be applied in studies of inflammatory processes involved in critical and chronic illnesses, which remain a major unmet need.

19 August 2016 in Science
Verified
Journal Article
Closed access
PDF file
KSKarin Stettler
Karin Stettler
MBMartina Beltramello
Martina Beltramello
DEDiego A. Espinosa
Diego A. Espinosa
VGVictoria Graham
Victoria Graham
ACAntonino Cassotta
Antonino Cassotta
DCDavide Corti
Davide Corti
Characterizing the Zika virus antibody response: Given the public health emergency that Zika virus poses, scientists are seeking to understand the Zika-specific immune response. Stettler et al. analyzed 119 monoclonal antibodies isolated from four donors that were infected with Zika virus during the present epidemic, including two individuals that had previously been infected with dengue virus, another member of the flavivirus family. Neutralizing antibodies primarily recognized the envelope protein domain III (EDIII) or quaternary epitopes on the intact virus, and an EDIII-targeted antibody protected mice against lethal infection. Some EDI/II-targeting antibodies cross-reacted with dengue virus in vitro and could enhance disease in dengue-infected mice. Whether dengue and Zika virus antibodies cross-react in humans remains to be tested. Science , this issue p. 823

6 October 2021 in Nature
Verified
Journal Article
Closed access
PDF file
FCFernando P. Canale
Fernando P. Canale
CBCamilla Basso
Camilla Basso
GAGaia Antonini
Gaia Antonini
MPMichela Perotti
Michela Perotti
NLNing Li
Ning Li
RGRoger Geiger
Roger Geiger

23 January 2015 in Science
Verified
Journal Article
Closed access
PDF file
SBSimone Becattini
Simone Becattini
DLDaniela Latorre
Daniela Latorre
FMFederico Mele
Federico Mele
MFMathilde Foglierini
Mathilde Foglierini
CGCorinne De Gregorio
Corinne De Gregorio
FSFederica Sallusto
Federica Sallusto
For T cells, variety is the spice of life: CD4 + helper T cells come in a variety of flavors. This allows them to respond in a manner that is tailored to the pathogen they encounter. Becattini et al. wondered whether multiple “flavors” of human CD4 + T cells respond to specific stimuli or if just one flavor dominates. To find out, they stimulated human memory CD4 + T cells with a fungus, a bacteria, or a vaccine antigen. Multiple helper cell subsets participated in each response. T cell receptor sequencing revealed that in some cases, T cells with the same specificity acquired different helper cell fates. Thus, there is more heterogeneity in human T cell responses than previously appreciated. Science , this issue p. 400

20 May 2016 in Annual Review of Immunology
Verified
Journal Article
Closed access
FSFederica Sallusto
Federica Sallusto
CD4+T helper (Th) cells play a central role in the adaptive immune response by providing help to B cells and cytotoxic T cells and by releasing different types of cytokines in tissues to mediate protection against a wide range of pathogenic microorganisms. These functions are performed by different types of Th cells endowed with distinct migratory capacities and effector functions. Here we discuss how studies of the human T cell response to microbes have advanced our understanding of Th cell functional heterogeneity, in particular with the discovery of a distinct Th1 subset involved in the response to Mycobacteria and the characterization of two types of Th17 cells specific for extracellular bacteria or fungi. We also review new approaches to dissect at the clonal level the human CD4+T cell response induced by pathogens or vaccines that have revealed an unexpected degree of intraclonal diversification and propose a progressive and selective model of CD4+T cell differentiation.

19 September 2018 in Nature
Verified
Journal Article
Closed access
PDF file
DLDaniela Latorre
Daniela Latorre
UKUlf Kallweit
Ulf Kallweit
EAEric Armentani
Eric Armentani
MFMathilde Foglierini
Mathilde Foglierini
FMFederico Mele
Federico Mele
FSFederica Sallusto
Federica Sallusto